Orient Europharma Co Ltd (4120) — Financial Flexibility Index
Orient Europharma Co Ltd (4120) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of NT$-110.17 Million (operating CF NT$-157.84 Million minus capex NT$47.67 Million) represents 0% of total liabilities (NT$4.54 Billion). Check Orient Europharma Co Ltd (4120) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Orient Europharma Co Ltd Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Orient Europharma Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see Orient Europharma Co Ltd cash conversion from operations.
Annual Financial Flexibility Index for Orient Europharma Co Ltd (2015–2024)
Year-by-year free cash flow to debt coverage for Orient Europharma Co Ltd. Explore 4120 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.00x | NT$-20.91 Million | NT$-121.11 Million | NT$5.75 Billion | ▼ -114.6% |
| 2023 | 0.02x | NT$165.37 Million | NT$64.67 Million | NT$6.65 Billion | ▼ -58.7% |
| 2022 | 0.06x | NT$420.41 Million | NT$-218.75 Million | NT$6.99 Billion | ▼ -78.2% |
| 2021 | 0.28x | NT$1.64 Billion | NT$77.65 Million | NT$5.95 Billion | ▲ +39.4% |
| 2020 | 0.20x | NT$841.33 Million | NT$608.55 Million | NT$4.25 Billion | ▲ +127.9% |
| 2019 | 0.09x | NT$352.35 Million | NT$227.37 Million | NT$4.06 Billion | ▼ -37.9% |
| 2018 | 0.14x | NT$432.92 Million | NT$231.31 Million | NT$3.10 Billion | ▼ -63.1% |
| 2017 | 0.38x | NT$968.75 Million | NT$601.08 Million | NT$2.56 Billion | ▲ +189.9% |
| 2016 | 0.13x | NT$336.05 Million | NT$111.24 Million | NT$2.57 Billion | ▼ -68.7% |
| 2015 | 0.42x | NT$873.51 Million | NT$643.97 Million | NT$2.09 Billion | — |